Legacy Education (LGCY) Investor presentation summary
Event summary combining transcript, slides, and related documents.
Investor presentation summary
12 Feb, 2026Business overview and market opportunity
Operates six campuses in California, offering 70 programs with 3,495 enrolled students as of September 2025, focusing on allied healthcare, veterinary, and business fields.
Achieved 40% year-over-year revenue growth to $69.6M and 38% student enrollment growth.
Programs are designed for high ROI, shorter durations, and strong job placement, with a 75% placement rate and 82% NCLEX pass rate.
U.S. healthcare labor market faces significant shortages, with 1.3M current job openings and projected 1.9M new jobs by 2034.
For-profit schools confer the majority of degrees in key healthcare support roles, supporting workforce readiness.
Growth strategy and execution
Growth driven by organic enrollment, new program launches, and accretive acquisitions, with a 28% five-year enrollment CAGR.
Recent acquisitions include Central Coast College (2019), Integrity College of Health (2020), and Contra Costa Medical Career College (2024), contributing 35% of current enrollment.
New programs in nursing, imaging, veterinary, and dental fields launched since 2023, with continuous expansion planned.
Interactive Distance Learning (IDL) implemented, with 30–50% of students enrolled in hybrid or online formats.
Focus on buy vs. build for new campuses to accelerate scale and geographic reach.
Financial performance and unit economics
Adjusted EBITDA reached $11.0M in FY24 and $3.1M for the quarter ending September 2025, with a 16% margin.
Gross student acquisition cost is $1.5K, generating over 15x annual revenue per student ($23.1K).
Ended Q1 FY26 with $20.6M in cash, $25.9M working capital, and $133.2M market capitalization.
Generated $1.1M net cash from operations in Q1 FY26.
Revenue and enrollment growth outpaced prior three-year CAGR, with positive momentum across all KPIs.
Latest events from Legacy Education
- Q2 revenue up 40.7% and net income up 46%, fueled by enrollment and program expansion.LGCY
Q2 202612 Feb 2026 - Revenue up 35%, net income doubled, and expansion fueled by IPO and $8M acquisition.LGCY
Q1 202514 Jan 2026 - Q2 FY2025 revenue up 29.2% with record enrollment and expanded healthcare offerings.LGCY
Q2 202516 Dec 2025 - Virtual meeting to elect six directors, ratify auditor, and review governance and compensation.LGCY
Proxy Filing2 Dec 2025 - Annual proxy details voting items and confirms standard shareholder rights.LGCY
Proxy Filing2 Dec 2025 - IPO targets $10.28M for expansion, with strong growth but high regulatory risk.LGCY
Registration Filing29 Nov 2025 - IPO seeks $10.28M to fund growth, with strong financials but high regulatory exposure.LGCY
Registration Filing29 Nov 2025 - IPO seeks up to $11.95M for expansion, with strong growth but high regulatory risk.LGCY
Registration Filing29 Nov 2025 - Strong growth in revenue and enrollment, with IPO funding expansion amid regulatory risks.LGCY
Registration Filing29 Nov 2025